TY - JOUR
T1 - A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan
AU - Bennett, Heather
AU - Waser, Nathalie
AU - Johnston, Karissa
AU - Kao, Jia-Horng
AU - Lim, Young-Suk
AU - Duan, Zhongping
AU - Lee, Youn-Jae
AU - Wei, Lai
AU - Chen, Chien-Jen
AU - Sievert, William
AU - Yuan, Yong
AU - Li, Hong
PY - 2015
Y1 - 2015
N2 - Hepatitis C virus (HCV) infection is associated with substantial clinical and economic burden and is an important public health issue in Asia. The objective of this review was to characterize HCV epidemiology and related complications in China, Japan, South Korea and Taiwan. A search of electronic databases and conference abstracts identified 71 potentially relevant articles. Of those, 55 were included in the epidemiology review and 9 in the review of HCV-related complications. HCV prevalence in the general population was 1.6 in China, 0.6-0.9 in Japan, 0.6-1.1 in South Korea and 1.8-5.5 in Taiwan. Prevalence was higher for injecting drug users (48-90 ) and those with human immunodeficiency virus coinfection (32-85 ) and was lower for blood donors (
AB - Hepatitis C virus (HCV) infection is associated with substantial clinical and economic burden and is an important public health issue in Asia. The objective of this review was to characterize HCV epidemiology and related complications in China, Japan, South Korea and Taiwan. A search of electronic databases and conference abstracts identified 71 potentially relevant articles. Of those, 55 were included in the epidemiology review and 9 in the review of HCV-related complications. HCV prevalence in the general population was 1.6 in China, 0.6-0.9 in Japan, 0.6-1.1 in South Korea and 1.8-5.5 in Taiwan. Prevalence was higher for injecting drug users (48-90 ) and those with human immunodeficiency virus coinfection (32-85 ) and was lower for blood donors (
UR - http://link.springer.com/article/10.1007%2Fs12072-015-9629-x
U2 - 10.1007/s12072-015-9629-x
DO - 10.1007/s12072-015-9629-x
M3 - Article
SN - 1936-0533
VL - 9
SP - 378
EP - 390
JO - Hepatology International
JF - Hepatology International
IS - 3
ER -